Decarbonised pharmaceutical production as a business model
UCB Farchim
Decarbonised pharmaceutical production as a business model
UCB Farchim SA is integrating climate and water efficiency into its pharmaceutical production at its site in Bulle. Since 2019, CO₂ emissions have fallen by 33% and water consumption by 15%. This helps to conserve resources and safeguard production in the long term.
Nomated Business Model: Decarbonised pharmaceutical production as a business model
Company: UCB Farchim SA
